These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 993619)

  • 1. Lack of leukocyte migration inhibition by hepatitis B antigen and normal nonspecific immunoreactivity in asymptomatic carriers.
    Desaules M; Frei PC; Libanska J; Wuilleret B
    J Infect Dis; 1976 Nov; 134(5):505-9. PubMed ID: 993619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intradermal administration of Corynebacterium parvum on the immune response to hepatitis Bs antigen.
    Papaevangelou G; Sparros L; Vissoulis C; Kyriakidou A; Giokas G; Hadzimanolis J; Trichopoulos D
    J Med Virol; 1977; 1(1):15-9. PubMed ID: 609027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immunity in response to HBs antigen.
    Szkaradkiewicz A; Kiczka W
    Z Immunitatsforsch Immunobiol; 1978 Sep; 154(5):463-70. PubMed ID: 726550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of HBe/anti-HBe system and DNA polymerase activity in chronic hepatitis-B virus carriers on haemodialysis. A prospective study.
    Marchesini G; Zoli M; Angiolini A; Feliciangeli G; Santoro A; Ferroni P; Zanetti AR
    Nephron; 1981; 29(1-2):44-8. PubMed ID: 7329473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cellular immunity in 18 cirrhotic African carriers of hepatitis B virus surface antigen (HBsAg)].
    Sankale M; Agbetra M
    Bull Soc Pathol Exot Filiales; 1977; 70(4):435-7. PubMed ID: 580921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of PPD and BCG-induced leukocyte migration inhibition, delayed cutaneous hypersensitivity, lymphocyte transformation in vitro and humoral antibodies to PPD in man.
    Fleer A; van der Hart M; Blok-Schut BJ; Schellekens PT
    Eur J Immunol; 1976 Mar; 6(3):163-7. PubMed ID: 791653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immunity in the evolution of acute and chronic HBsAg hepatitis.
    Scalise G; Mura MS; Piersimoni C
    Ann Sclavo; 1981; 23(1):92-105. PubMed ID: 7294920
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA antigens in asymptomatic carriers of HBs antigen and in carriers of anti-HBs antibodies.
    Jagielski P; Sotnik D
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):207-12. PubMed ID: 749771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serologic analysis of HBc antigen in patients with HBs-antigen carrier state].
    Möller B; Hopf U; Shirpai M; Lobeck H
    Dtsch Med Wochenschr; 1985 Mar; 110(11):407-11. PubMed ID: 3979271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cell-mediated and humoral immunity in HBS-Ag carriers].
    Belozerov ES; Sagandykov BB; Shabalin VV; Arkhipov GS
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Sep; (9):55-7. PubMed ID: 386665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of (+)-cyanidanol-3 on the leukocyte migration inhibition test carried out in the presence of purified protein derivative and hepatitis B surface antigen.
    Vallotton JJ; Frei PC
    Infect Immun; 1981 May; 32(2):432-7. PubMed ID: 7251131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection and significance of anti-pre S2 in patients with hepatitis B and HBsAg carriers].
    Ding Z
    Zhonghua Yi Xue Za Zhi; 1990 Nov; 70(11):611-4, 42. PubMed ID: 1963350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Occurrence of hepatitis B carriers in 2 immigrant families].
    Sievers CJ
    Ugeskr Laeger; 1991 Apr; 153(16):1133. PubMed ID: 2024349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte stimulation in hepatitis B infections.
    Tong MJ; Wallace AM; Peters RL; Reynolds TB
    N Engl J Med; 1975 Aug; 293(7):318-22. PubMed ID: 1152922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-idiotypic humoral and cellular responses to antibody to hepatitis B surface antigen in hepatitis B viral infections.
    Rath S; Bal V; Mohite BJ; Haridas V; Naik SR; Kamat SA; Zuckerman AJ; Kamat RS
    Clin Exp Immunol; 1988 Sep; 73(3):360-5. PubMed ID: 3264769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigen e and its antibodies in acute serum hepatitis and in persons with a prolonged HBs-antigenemia].
    Paktoris EA; Trofimova LI; Sergeeva NA; Sinaĭko GA; Shakhgil'dian IV
    Vopr Virusol; 1979; (2):156-61. PubMed ID: 107654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of anti-delta antibodies in HBsAg carriers].
    Söyletir G; Babacan F; Göral M; Can A
    Mikrobiyol Bul; 1989 Apr; 23(2):97-101. PubMed ID: 2626106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immunity to hepatitis B surface antigen in man.
    Hanson RG; Hoofnagle JH; Minuk GY; Purcell RH; Gerin JL
    Clin Exp Immunol; 1984 Aug; 57(2):257-64. PubMed ID: 6235987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.